 |
 |
<http://www.ncbi.nlm.nih.gov/PubMed/> The N-methyl-D-aspartate receptor channel blocker amantadine does not cause histopathological alterations in human brain tissue. PMID: 10412804; UI: 99339149. Ethical Aspects of Neural Tissue Transplantation. PMID: 10411958. Nicotinic Acetylcholine Receptor Agonist SIB-1508Y Improves Cognitive Functioning in Chronic Low-Dose MPTP-Treated Monkeys. PMID: 10411585. Increased brain-derived neurotrophic factor-containing axons in the basal ganglia of patients with multiple system atrophy. PMID: 10411346; UI: 99337153. The need for phase III studies in experimental surgical treatments of PD PMID: 10410785; UI: 99338974. The case for neural tissue transplantation as a treatment for PD PMID: 10410784; UI: 99338973. Effect of long-term stimulation of the ventral intermediate thalamic nucleus on gait in PD PMID: 10410781; UI: 99338970. Long-term electrostimulation of the ventroposterolateral pallidum in the treatment of PD PMID: 10410780; UI: 99338969. Surgical treatment of levodopa-induced dyskinesias. PMID: 10410777; UI: 99338966. Image-guided electrophysiologically controlled posteroventral pallidotomy for the treatment of PD: a 28-case analysis. PMID: 10410775; UI: 99338964. Posteroventral medial pallidotomy in advanced PD PMID: 10410774; UI: 99338963. Traditional and complementary therapies in PD PMID: 10410773; UI: 99338962. Pragmatic physical therapy in PD: any scientific basis? PMID: 10410772; UI: 99338961. Interdisciplinary rehabilitation in PD PMID: 10410771; UI: 99338960. Effects of long-term, continuous subcutaneous apomorphine infusions on motor complications in advanced PD PMID: 10410769; UI: 99338958. Future delivery systems for apomorphine in patients with PD PMID: 10410768; UI: 99338957. Combined and selective monoamine oxidase inhibition in the treatment of depression in PD PMID: 10410764; UI: 99338953. Evidence suggesting the role of norepinephrine deficiency in late stages of PD PMID: 10410763; UI: 99338952. COMT inhibition with entacapone in the treatment of PD PMID: 10410761; UI: 99338950. Do we need more drugs to treat PD? PMID: 10410759; UI: 99338948. Art and PD PMID: 10410758; UI: 99338947. Notable europeans with PD PMID: 10410757; UI: 99338946. Objective assessment in PD: optoelectronic movement and force analysis in clinical routine and research. PMID: 10410755; UI: 99338944. Standardized quantitative measurements in PD PMID: 10410753; UI: 99338942. Evaluating community-based PD nurse specialists: rationale, methodology, and representativeness of patient sample in a large randomized controlled trial. PMID: 10410752; UI: 99338941. Hallucinations in PD: the clinical syndrome. PMID: 10410750; UI: 99338939. Clinicopathological heterogeneity and non-dopaminergic influences on behavior in PD PMID: 10410749; UI: 99338938. The place of dementia in PD: a methodologic saga. PMID: 10410748; UI: 99338937. Psychosis and hallucinations in PD PMID: 10410747; UI: 99338936. Visual and visual cognitive dysfunction in PD: spatial and chromatic vision. PMID: 10410745; UI: 99338934. Separating the primary autonomic failure syndromes, multiple system atrophy, and pure autonomic failure from PD PMID: 10410741; UI: 99338930. Urinary and anorectal function evaluation in PD PMID: 10410740; UI: 99338929. Preclinical diagnosis of PD PMID: 10410737; UI: 99338926. Apomorphine, a dopamine receptor agonist with remarkable antioxidant and cytoprotective properties. PMID: 10410734; UI: 99338923. P450 and heme oxygenase enzymes in the basal ganglia and their roles in PD PMID: 10410732; UI: 99338921. Oxidative stress and neuroprotection in PD: implications from studies on dopamine-induced apoptosis. PMID: 10410731; UI: 99338920. N-methyl(R)salsolinol, a dopamine neurotoxin, in PD PMID: 10410730; UI: 99338919. Nitric oxide in the pathogenesis of PD PMID: 10410728; UI: 99338917. Mitochondrial DNA in PD PMID: 10410727; UI: 99338916. Etiology of PD: contributions from 18F-DOPA positron emission tomography. PMID: 10410726; UI: 99338915. Time sequences of dopaminergic cell death in PD: indications for neuroprotective studies. PMID: 10410725; UI: 99338914. Idiopathic PD: a genetic and environmental model. PMID: 10410724; UI: 99338913. Toxins, genetics, and PD: the role of N-acetyltransferase 2. PMID: 10410722; UI: 99338911. Clinical genetic study of familial PD in Italy. PMID: 10410719; UI: 99338908. Genetic and environmental factors in the pathogenesis of PD PMID: 10410718; UI: 99338907. The Contursi kindred, a large family with autosomal dominant PD: implications of clinical and molecular studies. PMID: 10410717; UI: 99338906. Genetic and environmental factors in PD PMID: 10410716; UI: 99338905. Epidemiology of PD PMID: 10410715; UI: 99338904. Is PD an inherited condition? PMID: 10410714; UI: 99338903. Neurotrophins and cytokines in PD PMID: 10410713; UI: 99338902. Adenosine receptor antagonists and PD: actions of the A2A receptor in the striatum. PMID: 10410709; UI: 99338898. The metabolic landscape of PD PMID: 10410706; UI: 99338895. Functional consequences of dopaminergic degeneration in PD PMID: 10410704; UI: 99338893. The cognitive neuropsychology of PD: a functional neuroimaging perspective. PMID: 10410702; UI: 99338891. Pathophysiology of the motor cortex in patients with PD PMID: 10410699; UI: 99338888. Neurotrophins in the pathogenesis and potential treatment of PD PMID: 10410698; UI: 99338887. Glial cell participation in the degeneration of dopaminergic neurons in PD PMID: 10410697; UI: 99338886. Engineering neurons to treat PD PMID: 10409380. Engineering neurons for PD PMID: 10409349. Acute hypernatremia and neuroleptic malignant syndrome in PD PMID: 10408764; UI: 99335249. Does levodopa accelerate PD? PMID: 10408739; UI: 99335224. Verbal memory in non-demented patients with idiopathic PD PMID: 10408649; UI: 99335134. Slowing of reaction time in PD: the involvement of the frontal lobes. PMID: 10408646; UI: 99335131. Effects of intrasubthalamic injection of dopamine receptor agonists on subthalamic neurons in normal and 6-hydroxydopamine-lesioned rats: an electrophysiological and c-Fos study. PMID: 10408602; UI: 99335087. Chronic subthalamic nucleus stimulation reduces medication requirements in PD PMID: 10408541; UI: 99335026. Nigral endothelial dysfunction, homocysteine, and PD PMID: 10408491; UI: 99334976. Event-related potentials reveal memory deficits in PD PMID: 10407205. Regulation of parkinsonian speech volume: the effect of interlocuter distance. PMID: 10406989. 123I-metaiodobenzylguanidine myocardial scintigraphy in PD PMID: 10406987. Detection of preclinical PD in at-risk family members with use of [123I]beta-CIT and SPECT: an exploratory study. PMID: 10405696; UI: 99334168. Quantification and visualization of defects of the functional dopaminergic system using an automatic algorithm. PMID: 10405125; UI: 99332011. A therapeutic role for melatonin antagonism in experimental models of PD PMID: 10405106; UI: 99331992. New and emerging therapies for PD PMID: 10404979; UI: 99331865. Induction of a midbrain dopaminergic phenotype in Nurr1-overexpressing neural stem cells by type 1 astrocytes. PMID: 10404157. A linear endothelin-1 analogue: solution structure of ET-1[Aib1,3,11,15, Nle7] by nuclear magnetic resonance spectroscopy and molecular modelling. PMID: 10403428; UI: 99330222. Differential regulation of glutamate, aspartate and gamma-amino-butyrate release by N-methyl-D-aspartate receptors in rat striatum after partial and extensive lesions to the nigro-striatal dopamine pathway. PMID: 10403427; UI: 99330221. Motor learning by imagery is differentially affected in Parkinson's and Huntington's diseases. PMID: 10403020; UI: 99331452. Distribution of the catecholaminergic neurons in the central nervous system of human embryos and fetuses. PMID: 10402270; UI: 99330523. Parvocellular and magnocellular visual processing in spinocerebellar degeneration and PD: an event-related potential study. PMID: 10402092; UI: 99328542. PD and lower limb somatosensory evoked potentials: apomorphine-induced relief of the akinetic-rigid syndrome and vertex P37-N50 potentials. PMID: 10402029; UI: 99328456. R- and S-salsolinol are not increased in cerebrospinal fluid of Parkinsonian patients. PMID: 10402028; UI: 99328455. Visual event-related potential changes at two different tasks in nondemented PD PMID: 10402025; UI: 99328452. SSRI-induced parkinsonism may be an early sign of future PD PMID: 10401924; UI: 99328351. Function of the cerebellum in Parkinsonian rest tremor and Holmes' tremor. PMID: 10401791; UI: 99328218. Levodopa induces a cytoplasmic localization of D1 dopamine receptors in striatal neurons in PD PMID: 10401786; UI: 99328213. Positron emission tomographic measurement of acetylcholinesterase activity reveals differential loss of ascending cholinergic systems in PD and progressive supranuclear palsy. PMID: 10401781; UI: 99328208. Neuronal activity in the basal ganglia in patients with generalized dystonia and hemiballismus. PMID: 10401777; UI: 99328204. Can calcium antagonists provide a neuroprotective effect in PD? PMID: 10400399; UI: 99325986. Tremor-frequency (3-6 Hz) activity in the sensorimotor arm representation of the internal segment of the globus pallidus in patients with PD PMID: 10400229; UI: 99325816. janet paterson 52 now / 41 dx / 37 onset snail-mail: PO Box 171 Almonte Ontario K0A 1A0 Canada website: a new voice <http://www.geocities.com/SoHo/Village/6263/> e-mail: <[log in to unmask]>